Abstract:Breast cancer is a malignant tumor that predominantly affects women. The incidence of breast cancer has risen annually and is increasingly occurring in younger population, posing a significant threat to women’s health. Estrogen receptor-positive breast cancer is the most prevalent subtype, accounting for 75% of all cases. Endocrine therapy, particularly with tamoxifen, serves as the primary treatment for these subtypes. However, due to the highly heterogeneous nature of breast cancer, some patients remain at risk for recurrence even after undergoing tamoxifen treatment. Therefore, it is essential to investigate the mechanism of tamoxifen in breast cancer treatment from a single-cell perspective. In comparison to single-cell genomics and single-cell proteomics, single-cell metabolomics can offer a clearer representation of the chemical changes occurring within individual cells by measuring the end products of cellular activity—metabolites. Thus, this approach can provide a more direct reflection of the differences between cells. In this study, single-cell mass cytometry was employed to investigate metabolite alterations in MCF-7 cells upon exposure to tamoxifen, aiming to elucidate its mechanism from a single-cell perspective. The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay was utilized to assess the impact of tamoxifen on MCF-7 cell proliferation and established optimal conditions for subsequent therapies involving these cells. The results showed that 576 metabolites under positive ion mode and 480 metabolites under negative ion mode are identified by using single-cell mass cytometry approach. In total, 811 metabolites are detected in MCF-7 cells without tamoxifen treatment compared to 776 metabolites identified following tamoxifen administration. It demonstrated that metabolites observed under negative ion mode effectively distinguish between MCF-7 cells treated with and without tamoxifen. Exposure to tamoxifen can result in upregulation of 28 metabolites and downregulation of 59 metabolites, and these changes predominantly influence metabolic pathways including taurine-hypotaurine metabolism, caffeine metabolism, cysteine-methionine metabolism, glycine-serine-threonine metabolism, purine metabolism, starch-sucrose metabolism, and pyrimidine metabolism. The findings indicated that the intervention of the aforementioned metabolites and metabolic pathways may represent one of the mechanisms through which tamoxifen exerts its effects against estrogen receptor-positive breast cancer. This study employed single-cell metabolomics based on mass spectrometry to explore the metabolic alterations in breast cancer cells induced by tamoxifen, which is often overlooked in metabolomics studies based on bulk cells. Furthermore, it elucidates the mechanism of tamoxifen’s action against estrogen receptor-positive breast cancer from a single-cell metabolomic perspective, thereby provides valuable insights for understanding the mechanisms underlying other therapeutic agents.

Study on the Effects of 17Β-Oestradiol and Tamoxifen on the Content of Intracellular Proteins by Itraq Labeling /LC-MALDI-TOF-TOF Analysis

[Analysis of the Effects of 17Beta-Oestradiol and Serum Deprivation on the Contents of Proteins in Breast Cancer Cells by Isobaric Tags for Relative and Absolute Quantification and Two-Dimensional Liquid Chromatography-Tandem Mass Spectrometry].

[Effect of Evn-50 on Cell Growth and Apoptosis in Tamoxifen-Resistance Human Breast Cancer Cell Line MCF-7/TAM-R].

[A Study on the Effect of Tanshinone II A Against Human Breast Cancer in Vivo].

Identification of differentially expressed genes in human breast cancer cells induced by 4-hydroxyltamoxifen and elucidation of their pathophysiological relevance and mechanisms

Proteomic Analysis Reveals Major Proteins and Pathways That Mediate the Effect of 17-β-Estradiol in Cell Division and Apoptosis in Breast Cancer MCF7 Cells

Proteomics Analysis of Tamoxifen-induced Autophagic MCF-7 Cells

Effect of Tamoxifen and Megestrol Acetate on Growth and Apoptosis in MCF-7 Breast Cancer Cell Strain in Vitro

The Effect of Anastrozole on Mrna Expression of Oestrogen Related Gene in MCF-7 Breast Cancer Cells

Effects of 17-β-Estradiol on Proliferation of Vascular Smooth Muscle Cells Induced by Thrombin and c-fos,Bcl-2 Expression

The effect of estrogen and tamoxifen on the growth of endometrial carcinoma cell

Study on the Mechanism of Tamoxifen Against Breast Cancer by Mass Spectrometry Based Single-Cell Metabolomics

Experimental Study on Inhibition of Bioactivity of Tamoxifen-Resistant Breast Cancer Cells by Emodin

Effect of Estrogen and Progesterone on the Expression of RCAS1 in Breast Cancer Cell Line MCF-7

Function of Estrogen Receptor Isoforms Α and Β in Endometrial Carcinoma Cells

Effects of Triiodothyronine on Estrogen Receptor-Α and Thyroid Hormone Receptor-Β in Breast Cancer Cells

[Effect of Mitogen-Activated Protein Kinase Signal Transduction in Non-Estrogen Antagonistic Mechanism of Tamoxifen].

Comparative Proteomic Analysis of Irradiation-Induced Radioresistant Breast Cancer Cells Using Label-Free Quantitation

Investigation of the Effect of Tamoxifen on hERG1 Potassium Channel Gene Expression in MCF-7 Cell Line

The Effect of Progesterone and Tamoxifen on Cell Proliferation and the Expression of Estrogen Receptor Related Receptor of Endometrial Carcinoma

Studies on Resistant Induction of Breast Cancer Cell MCF-7 to Tamoxifen in Vitro